Bayer Schering Pharma

Bayer Links (Global)

Special Interest

Innovations benefit health and well-being of people Bayer Schering Pharma AG is now among the world leading pharmaceutical companies with a focus on both primary and speciality care. We aim for innovations that will benefit the health and well-being of people and invests more than EUR 1.7 Billion per year in reasearch and development of innovative medicines. In Vietnam, Bayer Schering Pharma is represented through the Resident Representative Office of Bayer South East Asia Pte. Ltd. based in Ho Chi Minh City and promotes products in five different categories: 1. Primary Care and Andrology with the leading brands Ciprobay and Avelox (anti-infectives), Glucobay (Diabetes treatment), Adalat (anti-hypertensive) and Levitra (erectile dysfunction). 2. Women’s Health Care with a focus on oral contraception (Diane 35 and Gynera) and hormon therapy (Climen, Progynova, Cyclo Progynova, Primolut N). 3. Diagnostic Imaging Contrast Media for X-ray (Ultravist, Urografin) and MRI examinations (Magnevist) 4. Oncology: Treatment of different forms of Leukemia (Fludara), Prostate Cancer (Androcur), Hypercalcimia and Osteolysis due to malignancy (Bonefos) 5. Specialized Therapeutics: Treatment of pulmonary hypertension and peripheral arterial occlusive disease (llomedin and Ventavis)